IMR Press / CEOG / Volume 49 / Issue 9 / DOI: 10.31083/j.ceog4909195
Open Access Review
Infertility and the Endometrium
Show Less
1 Hudson Institute of Medical Research and Department of Molecular and Cellular Medicine, Monash University, 3168 Melbourne, Australia
2 Department of Obstetrics and Gynaecology, Gynaecology Research Centre, University of Melbourne, The Royal Women's Hospital, 3010 Melbourne, Australia
*Correspondence: lois.salamonsen@hudson.org.au (Lois A. Salamonsen)
Academic Editor: Beverley Vollenhoven
Clin. Exp. Obstet. Gynecol. 2022, 49(9), 195; https://doi.org/10.31083/j.ceog4909195
Submitted: 11 April 2022 | Revised: 14 July 2022 | Accepted: 19 July 2022 | Published: 24 August 2022
(This article belongs to the Special Issue Infertility)
Copyright: © 2022 The Author(s). Published by IMR Press.

This is an open access article under the CC BY 4.0 license.

Abstract

Background: A couple’s infertility can originate from the male and/or the female. In women, the uterus provides the site where the maternal-fetal interface is established and maintained. Final blastocyst development occurs within the uterine cavity, then the blastocyst must attach to and implant into the endometrium (the inner uterine surface), via its outermost trophectodermal cells. Beneath the epithelium, these differentiate into syncytial trophoblast and invasive trophoblast — the latter progress through the endometrium to invade the spiral arteries converting them to the flaccid blood sacs of the placenta. Therefore, the endometrium plays a critical role in establishment of pregnancy. Objectives: To critically examine current knowledge of endometrial preparation for blastocyst implantation and placental development at the cellular and molecular level and to evaluate measures to improve implantation success. Mechanism: Literature searching by leading experts in the field. Findings: A wealth of new knowledge resulting from ‘omics’ technologies and new functional models has greatly enhanced our knowledge, but this information is yet to be translated into enhanced outcomes. Conclusions: The endometrium remains the ‘black box’ of infertility. Extensive trials do not support current adjuvant therapies as being better than placebo while effectively timed testing for endometrial preparedness for implantation is still urgently needed.

Keywords
receptive endometrium
implantation
cellular composition
molecular analysis
embryo-maternal interactions
adjuvant therapies
testing for receptivity
infertility
Figures
Fig. 1.
Share
Back to top